Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
6-K
Shareholder vote
confidence 75%
filed 2026-07-24
EX-99.1
GCL Global Holdings Ltd is soliciting shareholder votes at an extraordinary general meeting scheduled for August 7, 2026, on four substantive proposals: authorization for a 10:1 to 30:1 share consolidation with board discretion on timing and ratio, increase in authorized share capital post-consolidation, adoption of amended memorandum and articles of association, and meeting adjournment authority. The share consolidation and capital restructuring represent material governance and capital structure events affecting investor assessment.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-24
This 8-K Item 5.07 discloses the results of Tenon Medical's 2026 Annual Meeting of Stockholders held on July 23, 2026. The filing reports voting outcomes on six matters: election of seven directors, ratification of auditors (Haskell & Whitee LLP), approval of a reverse stock split (1:2 to 1:35 ratio), approval of shares underlying convertible debt from March 2026 financing, approval of future dilutive issuances under Nasdaq rules, and adjournment authority. All six proposals were approved. The reverse stock split and dilutive issuance approvals are material capital structure events affecting shareholders.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-24
The exhibit is a press release announcing the results of Euroholdings' 2026 Annual Meeting of Shareholders held on July 23, 2026. It discloses that shareholders elected two Class B directors (Panagiotis Kyriakopoulos and Christos Triantafillidis) and ratified the appointment of Deloitte as independent auditors. This is a direct disclosure of shareholder vote results, which is material to investors as it affects board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-24
Item 5.07
This is a clear disclosure of shareholder voting results from Booz Allen Hamilton's Annual Meeting of Stockholders held on July 22, 2026, covering four proposals: election of ten directors, ratification of Ernst & Young LLP as independent auditor, advisory vote on named executive officer compensation, and a stockholder proposal. The filing presents final vote tallies for each matter, which is the quintessential content of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-24
Item 5.07
On July 22, 2026, the Company held a Special Meeting of Stockholders at which shareholders voted on six proposals: election of six directors, ratification of Sadler, Gibb & Associates as auditors, advisory approval of named executive officer compensation, approval of the 2025 and 2026 equity incentive plans, and adjournment authority. Vote counts for each proposal are disclosed.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-24
The 6-K discloses results of an Annual and Extraordinary General Meeting of Shareholders held on July 23, 2026, where shareholders voted on and approved all agenda items except Proposal No. 6. This is a direct disclosure of shareholder vote results, which is material to investors as it reflects governance decisions and shareholder approval of corporate actions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-24
Item 5.07
This is a clear disclosure of shareholder vote results from Jazz Pharmaceuticals' 2026 Annual General Meeting held on July 23, 2026. The filing reports voting outcomes on six proposals including director elections (Proposal 1), auditor ratification (Proposal 2), executive compensation approval (Proposal 3), and board authority matters (Proposals 4-5), with detailed vote tallies for each. This is a quintessential Item 5.07 shareholder vote results disclosure that is material to investors as it reflects shareholder approval of key governance and compensation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-24
Item 5.07
System1 held its 2026 annual meeting of stockholders on July 22, 2026, with voting results on three proposals: approval of Series A Cumulative Convertible Preferred Stock issuance, election of three Class I directors (Michael Blend, Caroline Horn, and Taryn Naidu), and ratification of Deloitte and Touche LLP as independent auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
Brown-Forman held its Annual Meeting of Stockholders on July 23, 2026. Shareholders voted on three proposals: election of 11 directors (all elected), advisory approval of executive compensation (approved), and ratification of Ernst & Young LLP as independent auditor (ratified).
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-23
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 22, 2026. The filing reports the voting outcomes for three proposals: election of seven directors, advisory approval of named executive officer compensation, and ratification of Crowe LLP as independent auditor. The detailed vote tallies (For, Against, Abstain, Broker Non-votes) for each proposal are the core content of Item 5.07, which is the standard Item for reporting shareholder meeting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
This 8-K Item 5.07 discloses the results of a special stockholder meeting held on July 23, 2026, where shareholders voted on two proposals: (1) adoption of a Merger Agreement with Sun Pharmaceutical entities, which passed with 192.8 million votes for and 2.6 million against, and (2) advisory approval of merger-related executive compensation, which also passed. The disclosure includes voting tallies, quorum information, and record date details—all hallmarks of shareholder vote results. The merger itself is material, and the shareholder approval is a critical milestone in the transaction's completion.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
This Item 5.07 disclosure presents the final voting results from Maison Solutions Inc.'s annual meeting of stockholders held on July 22, 2026. The filing reports detailed vote tallies for two proposals: (1) election of five directors (John Xu, Alexandria M. Lopez, Mark Willis, Bin Wang, and Dr. Xiaoxia Zhang) and (2) ratification of Kreit & Chiu CPA LLP as independent auditors for fiscal year 2027. This is a classic shareholder_vote_results event, as it discloses the outcome of matters voted upon at an annual meeting of security holders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
This is a clear disclosure of shareholder voting results from the 2026 Annual Meeting of Stockholders held on July 22, 2026, covering four proposals: director elections, say-on-pay advisory vote, auditor ratification, and a reverse stock split amendment. The filing directly reports vote tallies (For, Against, Withheld/Abstain, Broker Non-Votes) for each proposal, which is the core content of Item 5.07 shareholder vote results disclosures. The reverse stock split proposal is particularly material as it addresses Nasdaq compliance concerns regarding minimum bid price requirements.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-23
The 6-K discloses results of Tokyo Lifestyle Co., Ltd.'s 20th Annual General Meeting of Shareholders held on June 26, 2026. The filing reports shareholder approval of five agenda items: financial statements, Articles of Incorporation amendments, a year-end dividend of JPY1.890 per share, appointment of Sakurazaka Audit Corporation as Accounting Auditor, and appointment of three Corporate Auditors. This is a classic shareholder vote results disclosure under Item 5.07 equivalent, and the dividend approval and auditor/corporate auditor appointments are material governance and capital allocation matters.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
The filing discloses results of a special meeting of stockholders held on June 22, 2026, where shareholders voted on four proposals: extension of the business combination deadline, amendment to the trust agreement, elimination of redemption limitations, and adjournment. Item 5.07 provides detailed voting results for each proposal, with overwhelming approval (1,897,828 FOR votes vs. 900 AGAINST on all substantive proposals). This is a classic shareholder vote results disclosure under Item 5.07, and the outcomes are material to a SPAC's continued operations and timeline.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 45%
filed 2026-07-23
The document is a distance voting ballot for an Extraordinary General Meeting scheduled for 08/28/2026, not a report of voting results. It presents three material merger resolutions (Juno, Tijoá Energia, Retiro Baixo, and NE Janapu) for shareholder approval, but the vote has not yet occurred. This is a pre-meeting disclosure furnishing voting instructions and merger proposals, not a post-meeting results announcement. The most defensible classification is `shareholder_vote_results` as the closest fit, though technically this is a voting ballot preceding the meeting rather than results following it; alternatively, this could be `ma_activity` given the four mergers proposed, but the document's primary function is shareholder voting mechanics rather than M&A announcement.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 75%
filed 2026-07-23
The 6-K furnishes a distance voting ballot for an Extraordinary General Meeting (EGM) scheduled for 08/28/2026, presenting three material merger resolutions: approval of the mergers of Juno Participações, Tijoá Participações, Retiro Baixo Energética, and SPE Nova Era Janapu Transmissora into AXIA Energia. While this is technically a pre-vote notice rather than post-vote results, it discloses the shareholder voting mechanism and substantive M&A activity requiring shareholder approval. The mergers themselves constitute material acquisition activity under the taxonomy, though the document is the voting ballot rather than results announcement.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 25%
filed 2026-07-23
This is a call notice for an Extraordinary General Meeting scheduled for August 28, 2026, not a report of voting results. The document announces shareholder approval items (mergers of Juno, Tijoá Energia, Retiro Baixo, and NE Janapu into AXIA Energia) but does not disclose the outcome of a vote. The proper classification should be governance-related, but the taxonomy lacks a specific "shareholder_meeting_notice" or "shareholder_vote_scheduled" type. This is a pre-vote notice, not a post-vote result.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-23
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from the July 22, 2026 Annual Meeting. The filing reports voting outcomes on four proposals: election of five directors, approval of a stock plan amendment, advisory approval of executive compensation, and ratification of the auditor (Baker Tilly US, LLP). All proposals passed with majority support, and the detailed vote tallies are provided for each nominee and proposal.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-23
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of Ultralife Corporation's 2026 Annual Meeting of Stockholders held on July 22, 2026. The filing presents detailed voting results for four proposals: election of five directors, ratification of the independent auditor (WithumSmith+Brown, PC), advisory approval of executive compensation, and a non-binding advisory vote on the frequency of future say-on-pay votes (determined to be three years). All material shareholder votes are disclosed with vote counts and percentages, making this a standard shareholder vote results disclosure that is material to investors assessing corporate governance and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-07-23
Item 5.07
Uranium Energy Corp held its Annual Meeting of Stockholders on July 23, 2026, with shareholders voting on three matters: election of six directors (Amir Adnani, Spencer Abraham, David Kong, Vincent Della Volpe, Gloria Ballesta, and Trecia Canty), ratification of PricewaterhouseCoopers LLP as independent auditor, and advisory approval of named executive officer compensation. All three proposals passed with detailed vote tallies reported.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
The filing discloses results of Syra Health Corp.'s Annual Meeting of Stockholders held on July 23, 2026, under Item 5.07. The document presents voting results for three proposals: election of five directors, ratification of M&K CPAs as independent auditor, and approval of an amendment to the 2022 Omnibus Equity Incentive Plan increasing available Class A shares to 4,100,000. This is a standard shareholder vote results disclosure material to investors assessing governance and capital structure decisions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
The filing discloses results of the 2026 Annual Meeting of Stockholders held on July 23, 2026, with detailed voting outcomes for eight proposals including charter amendments establishing a classified board, director elections, auditor ratification, say-on-pay votes, and approval of an amended equity incentive plan. Item 5.07 explicitly reports shareholder vote results, which is the primary disclosure focus of this 8-K.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-23
EX-99.1
This exhibit discloses the outcome and voting results of Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026, including the Scrutinizer's Report on remote e-voting and e-voting during the AGM, and agenda-wise voting details. Seven resolutions were voted on and declared passed by requisite majority, including adoption of audited financial statements, declaration of dividend, director re-appointments and appointments, auditor appointment, and cost auditor remuneration ratification. This is a classic shareholder_vote_results disclosure under Item 5.07 equivalent.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-23
EX-99.1
This exhibit discloses the results of shareholder votes at Dr. Reddy's 42nd Annual General Meeting held on July 23, 2026. The members approved three resolutions: (1) re-appointment of Dr. K P Krishnan as an Independent Director for a second five-year term; (2) appointment of Mr. Srikanth Velamakanni as an Independent Director; and (3) appointment of Deloitte Haskins & Sells, LLP as Statutory Auditors. These are material governance matters affecting board composition and audit oversight, disclosed under Regulation 30 of the SEBI Listing Regulations.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 45%
filed 2026-07-23
EX-99.1
This is an announcement of an upcoming 2026 Annual General Meeting scheduled for September 11, 2026, not a disclosure of vote results. The document announces the meeting agenda and proposes a material increase in authorized share capital to US$5,000,000 to support strategic growth, but does not report the outcome of shareholder voting. The primary material disclosure is the proposed share capital increase and strategic initiatives (Asia-Pacific expansion into BESS and AI data centers, potential North American facility), which are operational and financial in nature rather than governance voting results.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-23
Item 5.07
This is a clear disclosure of shareholder voting results from Ready Capital's July 17, 2026 annual meeting of stockholders, filed under Item 5.07. The filing reports results for four proposals: election of seven directors, ratification of Deloitte & Touche LLP as independent auditor, advisory approval of named executive officer compensation, and approval of the Amended and Restated 2023 Equity Incentive Plan. All proposals passed with substantial majorities, making this a material governance event that affects investor understanding of the company's leadership and capital structure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-23
Item 5.07
This Item 5.07 disclosure reports the results of Samsara's annual meeting of stockholders held on July 22, 2026, including voting outcomes on three proposals: election of eight directors, ratification of Deloitte & Touche LLP as auditors, and an advisory vote on named executive officer compensation. The detailed vote tallies for each proposal are the core content of the filing, making this a textbook shareholder_vote_results event.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-23
Item 5.07
The filing discloses results of a shareholder action by written consent on July 20, 2026, in which holders of 31,500,087 shares (100% of voting power) elected ten directors to the Board and ratified the appointment of PricewaterhouseCoopers LLP as the independent auditor for fiscal 2026. This is a classic Item 5.07 shareholder vote result disclosure, material to investors as it establishes the composition of the Board and confirms the auditor.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This is a clear disclosure of shareholder vote results from Capital Southwest Corporation's 2026 Annual Meeting held on July 22, 2026. The filing reports voting outcomes for six proposals: election of six directors, advisory approval of named executive officer compensation, frequency of advisory compensation votes, ratification of RSM US LLP as independent auditor, and approval to adjourn for a Charter Amendment vote. The detailed vote tallies (votes for, against, abstentions, and broker non-votes) for each proposal are the core content of Item 5.07.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-22
EX-99.1
This exhibit reports the voting results from a special shareholder meeting held on July 22, 2026, where shareholders voted on a share issuance resolution approving the issuance of up to 421.8 million common shares in connection with Equinox Gold's acquisition of Orla Mining Ltd. The disclosure of shareholder vote results is a direct match to the `shareholder_vote_results` event type, and the material acquisition component (issuance of a substantial number of shares for an M&A transaction) makes this material to investors.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
Hudson Acquisition I Corp. held a Special Meeting of stockholders on July 17, 2026, where shareholders voted to approve an Extension Amendment extending the deadline for completing a Business Combination from July 18, 2026 to April 18, 2027 (with up to nine one-month extensions), and approved an adjournment proposal. Both proposals passed overwhelmingly with 2,070,575 votes in favor, 2 against, and 0 abstentions.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This is a classic Item 5.07 disclosure reporting the results of an annual shareholder meeting held on July 16, 2026. The filing presents voting outcomes on three proposals: election of Class I directors (Richard Booth and Christine Detrick), advisory approval of named executive officer compensation, and ratification of Grant Thornton LLP as independent auditors. The detailed vote tallies (For, Against, Abstain, Broker Non-Votes) for each proposal are the core content of the disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
This disclosure reports the results of a special shareholder meeting held on July 16, 2026, where security holders voted on two proposals: approval of a plan of liquidation and dissolution of the Fund, and termination of its BDC status under the Investment Company Act of 1940. Both proposals passed with 70.45% approval from LLC Members (the beneficial owners). This is a classic shareholder vote result disclosure under Item 5.07, and the liquidation and BDC termination constitute material events affecting the registrant's continued existence and status.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-22
EX-99.1
This press release discloses the results of a Special Meeting of Shareholders held on July 22, 2026, where Equinox Gold shareholders voted to approve the share issuance resolution in connection with the proposed business combination with Orla Mining Ltd. The voting results show 507,548,903 votes in favor (99.83%) and 866,815 against (0.17%), representing 64.43% of outstanding shares. This is a material shareholder vote result directly tied to a significant M&A transaction.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the results of ZW Data Action Technologies' Annual Meeting of stockholders held on July 22, 2026, including voting outcomes on four matters: election of seven directors, ratification of independent accountants (ARK Pro CPA & Co.), ratification of the 2026 Omnibus Equity Incentive Plan, and approval of an increase in authorized shares. The detailed voting tallies (For/Against/Abstain/Broker Non-Votes) for each proposal are the core content of this filing, which is the standard form and substance of a shareholder vote results disclosure under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the final voting results from Genesco Inc.'s Annual Meeting of Shareholders held on July 21, 2026, including election of nine directors, advisory approval of named executive officer compensation, approval of the Fourth Amended and Restated 2020 Equity Incentive Plan, and ratification of Deloitte & Touche LLP as independent auditor. The filing presents tabulated vote counts for each matter, which is the core purpose of Item 5.07 shareholder vote results disclosures.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This Item 5.07 discloses the results of a special stockholder meeting held on July 22, 2026, where TMHC shareholders voted on three proposals: (1) adoption of a Merger Agreement with Berkshire Hathaway Inc. (75,830,360 votes for, 2,333,091 against), (2) advisory approval of executive compensation in connection with the merger (70,009,828 for, 8,095,053 against), and (3) an adjournment proposal (not submitted). The merger proposal received overwhelming shareholder approval, making this a material shareholder vote result that directly enables the M&A transaction to proceed.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the results of Spok Holdings' 2026 Annual Meeting of Stockholders held on July 21, 2026, including voting outcomes for director elections (six directors elected), ratification of Grant Thornton LLP as independent auditor, advisory approval of NEO compensation, and approval of the amended 2020 Equity Incentive Award Plan. The detailed vote tallies (For, Withheld, Abstentions, Broker Non-Votes) for each matter are presented in tabular form, which is the standard format for shareholder vote result disclosures under Item 5.07.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-22
The 6-K discloses the Final Synthetic Voting Map for an Extraordinary General Meeting held on April 30, 2026, presenting voting results for the election of Board of Directors members (items 1.1 and 1.2) and the election of the Chairman of the Board (items 2.1 and 2.2), with vote tallies representing 82.4% of voting capital. This is a direct disclosure of shareholder vote results as required by CVM Resolution No. 81/2021.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 95%
filed 2026-07-22
This exhibit is the official minutes of Vale's Extraordinary General Meeting held on July 22, 2026, disclosing shareholder voting results on three agenda items: removal of Daniel André Stieler (rendered moot by his prior resignation), election of Ieda Gomes Yell as an independent Board member (2,400,170,665 votes in favor), and election of Manuelino Silva de Sousa Oliveira as Chairman (1,977,262,848 votes in favor). The document explicitly records voting tallies, candidate information, and shareholder participation at 82.4% of share capital, making this a material governance event affecting board composition.
View raw filing on EDGAR →
6-K
Shareholder vote
confidence 85%
filed 2026-07-22
EX-99.1
Intercure Ltd. is soliciting shareholder approval for a reverse 5-to-1 share split and amendment to the Articles of Association at an Extraordinary General Meeting scheduled for August 12, 2026. The reverse split is driven by a Nasdaq non-compliance notice received on February 25, 2026 for failing to maintain a minimum $1.00 bid price, with delisting risk if the reverse split is not approved by the August 24, 2026 deadline.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the results of the Company's 2026 Annual Meeting of Members held on July 17, 2026, including voting outcomes on two matters: (1) re-election of three Class I directors (David R. Adler, Sheila A. Finnerty, and Andrew W. Tarica) with unanimous approval (3,753,190 votes for, 0 withheld), and (2) ratification of Deloitte & Touche LLP as independent auditor with unanimous approval (3,753,190 votes for, 0 against). The disclosure directly matches the shareholder_vote_results category as it presents formal voting results from an annual meeting of security holders.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the results of the Company's 2026 Annual Meeting of Members held on July 17, 2026, including voting outcomes on two matters: (1) re-election of three Class I directors (David R. Adler, Sheila A. Finnerty, and Andrew W. Tarica) with unanimous approval (3,224,700 votes for, 0 withheld), and (2) ratification of Deloitte & Touche LLP as independent auditor with overwhelming approval (3,217,200 for, 7,500 against). This is a classic shareholder vote results disclosure required under Item 5.07.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the results of TCW Direct Lending VII LLC's 2026 Annual Meeting of Members held on July 17, 2026. The filing presents voting outcomes for two matters: (1) re-election of three Class II directors (David R. Adler, Sheila A. Finnerty, and R. David Kelly) with unanimous approval (9,099,650 votes for, 0 withheld), and (2) ratification of Deloitte & Touche LLP as independent auditor with overwhelming approval (9,097,650 for, 2,000 against). This is a straightforward shareholder vote results disclosure, material to investors as it confirms board composition and auditor selection.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
This Item 5.07 disclosure reports the results of TCW Direct Lending LLC's 2026 Annual Meeting of Members held on July 17, 2026, including voting outcomes on three matters: re-election of a Class III director (David R. Adler), ratification of Deloitte & Touche LLP as independent auditor, and approval of a one-year extension of the Company's term. The filing presents vote tallies (For, Against, Withheld, Abstained, Broker Non-Votes) for each proposal, which is the core content of a shareholder vote results disclosure.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 97%
filed 2026-07-22
Item 5.07
Avanos Medical stockholders voted on July 22, 2026 to approve a merger agreement with American Industrial Partners affiliates at $25.00 per share in cash, with approximately 99.75% of shares voted in favor (35,119,793 for, 32,508 against, 55,248 abstain). The meeting also included a vote on executive compensation arrangements, with 30,620,395 shares in favor and 4,220,505 against.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This is a clear disclosure of shareholder voting results from the Annual Meeting of Stockholders held on July 16, 2026. The filing reports the final vote tallies for three proposals: election of directors (Proposal No. 1), approval of the 2026 Equity Incentive Plan (Proposal No. 2), and ratification of BDO USA, LLP as independent auditor (Proposal No. 3). This is a textbook Item 5.07 disclosure of shareholder vote results, which is material to investors as it confirms governance actions and board composition.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 95%
filed 2026-07-22
Item 5.07
Item 5.07 discloses the results of a shareholder vote (via written consent) in which 68.71% of voting power approved granting the Board discretionary authority to effect a reverse stock split in a 1-for-2 to 1-for-6 range. This is a classic shareholder vote result disclosure, material because reverse stock splits can affect share price, liquidity, and listing eligibility, and would influence a reasonable investor's assessment of the company's capital structure and exchange listing prospects.
View raw filing on EDGAR →
8-K
Shareholder vote
confidence 98%
filed 2026-07-22
Item 5.07
This is a clear Item 5.07 disclosure of shareholder vote results from DXC Technology's 2026 Annual Meeting held on July 21, 2026. The filing reports certified voting outcomes on five proposals: election of nine directors, ratification of Deloitte & Touche LLP as auditor, advisory approval of named executive officer compensation, rejection of a term extension to the 2017 Omnibus Incentive Plan, and approval of a term extension to the 2017 Non-Employee Director Incentive Plan. The detailed vote tallies for each proposal are provided, making this a textbook shareholder_vote_results disclosure that is material to investors assessing governance and capital allocation decisions.
View raw filing on EDGAR →